| Literature DB >> 21960592 |
Ellen Leich1, Alberto Zamo, Heike Horn, Eugenia Haralambieva, Bernhard Puppe, Randy D Gascoyne, Wing-Chung Chan, Rita M Braziel, Lisa M Rimsza, Dennis D Weisenburger, Jan Delabie, Elaine S Jaffe, Jude Fitzgibbon, Louis M Staudt, Hans-Konrad Mueller-Hermelink, Mariarita Calaminici, Elias Campo, German Ott, Luis Hernández, Andreas Rosenwald.
Abstract
A total of 90% of follicular lymphomas (FLs) harbor the translocation t(14;18) leading to deregulated BCL2 expression. Conversely, 10% of FLs lack the t(14;18), and the majority of these FLs do not express BCL2. The molecular features of t(14;18)-negative FLs remain largely unknown. We performed microRNA expression analysis in 32 FL grades 1 to 3A, including 17 t(14;18)-positive FLs, 9 t(14;18)-negative FLs without BCL2 expression, and 6 t(14;18)-negative FLs with BCL2 expression. MicroRNA profiles were correlated with corresponding mRNA expression patterns, and potential targets were investigated by quantitative PCR and immunohistochemistry in an independent validation series of 83 FLs. Statistical analysis identified 17 microRNAs that were differentially expressed between t(14;18)-positive FLs and t(14;18)-negative FLs. The down-regulation of miR-16, miR-26a, miR-101, miR-29c, and miR138 in the t(14;18)-negative FL subset was associated with profound mRNA expression changes of potential target genes involving cell cycle control, apoptosis, and B-cell differentiation. miR-16 target CHEK1 showed increased expression in t(14;18)-negative FLs, whereas TCL1A expression was reduced, in line with a partial loss of the germinal center B-cell phenotype in this FL subset. In conclusion, t(14;18)-negative FL have distinct microRNA profiles that are associated with an increased proliferative capacity and a "late" germinal center B-cell phenotype.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21960592 PMCID: PMC3217356 DOI: 10.1182/blood-2011-06-361972
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113